X-ray structure of the hRORα LBD at 1.63 Å:: Structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORα

被引:233
作者
Kallen, JA [1 ]
Schlaeppi, JM
Bitsch, F
Geisse, S
Geiser, M
Delhon, I
Fournier, B
机构
[1] Novartis Pharma AG, Cent Technol Prot Struct Unit, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Cent Technol Biomol Prod Unit, CH-4002 Basel, Switzerland
[3] Novartis Pharma AG, Bone Metab Unit, Arthrit & Bone Metab, CH-4002 Basel, Switzerland
关键词
ROR; atherosclerosis; cholesterol; nuclear receptor; coactivator; transcription factor;
D O I
10.1016/S0969-2126(02)00912-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The retinoic acid-related orphan receptor alpha (RORalpha) is an orphan member of the subfamily 1 of nuclear hormone receptors. No X-ray structure of RORalpha has been described so far, and no ligand has been identified-We describe the first crystal structure of the ligand binding domain (LBD) of RORalpha, at 1.63 Angstrom resolution. This structure revealed a ligand present in the ligand binding pocket (LBP), which was identified by X-ray crystallography as cholest-5-en-3beta-of (cholesterol). Moreover, RORalpha transcriptional activity could be modulated by changes in intracellular cholesterol level or mutation of residues involved in cholesterol binding. These findings suggest that RORalpha could play a key role in the regulation of cholesterol homeostasis and thus represents an important drug target in cholesterol-related diseases.
引用
收藏
页码:1697 / 1707
页数:11
相关论文
共 50 条
  • [1] Disruption of retinoid-related orphan receptor β changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice
    André, E
    Conquet, F
    Steinmayr, M
    Stratton, SC
    Porciatti, V
    Becker-André, M
    [J]. EMBO JOURNAL, 1998, 17 (14) : 3867 - 3877
  • [2] Coactivators for the orphan nuclear receptor RORα
    Atkins, GB
    Hu, X
    Guenther, MG
    Rachez, C
    Freedman, LP
    Lazar, MA
    [J]. MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) : 1550 - 1557
  • [3] Auwerx J, 1999, CELL, V97, P161
  • [4] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [5] Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects
    Billas, IML
    Moulinier, L
    Rochel, N
    Moras, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) : 7465 - 7474
  • [6] Difference structure-factor normalization for heavy-atom or anomalous-scattering substructure determinations
    Blessing, RH
    Smith, GD
    [J]. JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1999, 32 : 664 - 670
  • [7] Natural ligands of nuclear receptors have conserved volumes
    Bogan, AA
    Cohen, FE
    Scanlan, TS
    [J]. NATURE STRUCTURAL BIOLOGY, 1998, 5 (08) : 679 - 681
  • [8] Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains
    Bourguet, W
    Vivat, V
    Wurtz, JM
    Chambon, P
    Gronemeyer, H
    Moras, D
    [J]. MOLECULAR CELL, 2000, 5 (02) : 289 - 298
  • [9] CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA
    BOURGUET, W
    RUFF, M
    CHAMBON, P
    GRONEMEYER, H
    MORAS, D
    [J]. NATURE, 1995, 375 (6530) : 377 - 382
  • [10] A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
    Brown, MS
    Goldstein, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 11041 - 11048